Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular thiols and proteins represent a broad and heterogeneous class of molecules defined by the presence of reactive sulfhydryl (-SH) groups, which are essential for maintaining the cellular redox environment and protein functionality (Circu & Aw, 2010, Free Radic. Biol. Med.). This category includes low-molecular-weight antioxidants like glutathione (GSH) and a vast array of proteins where cysteine residues serve as catalytic centers or structural stabilizers (Pompella et al., 2003, Ital. J. Biochem.). In a pharmacological context, these molecules are often targeted by electrophilic agents, heavy metals, and reactive drug metabolites that form covalent adducts with sulfur atoms, potentially leading to enzyme inhibition or the depletion of antioxidant defenses (Kalinina et al., 2014, Curr. Med. Chem.). For example, platinum-based chemotherapeutics like cisplatin and gold-based compounds like auranofin interact with these thiol groups to exert their cytotoxic or anti-inflammatory effects (Casini et al., 2008, J. Biol. Inorg. Chem.). While modulating cellular thiols can be a potent therapeutic strategy for treating cancer or oxidative stress, the inherent lack of specificity poses significant risks, including off-target toxicity and the impairment of essential cellular signaling pathways (Hansen et al., 2009, Free Radic. Biol. Med.).
Drugs interact with cellular thiols and proteins primarily through covalent modification (alkylation, arylation, or metal-coordination) of sulfhydryl groups, which can deplete glutathione levels, inhibit redox-sensitive enzymes, or trigger the Nrf2-mediated antioxidant response (Kalinina et al., 2014, Curr. Med. Chem.).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular thiols and proteins.